Edition:
United States

Profile: Piramal Enterprises Ltd (PIRA.NS)

PIRA.NS on National Stock Exchange of India

1,853.00INR
6:11am EDT
Change (% chg)

Rs-7.35 (-0.40%)
Prev Close
Rs1,860.35
Open
Rs1,869.00
Day's High
Rs1,869.00
Day's Low
Rs1,845.00
Volume
26,189
Avg. Vol
107,216
52-wk High
Rs2,097.00
52-wk Low
Rs961.00

Piramal Enterprises Limited (PEL) is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries. The Company's pharmaceutical business consists of manufacturing and sale of own and traded bulk drugs and formulations. It operates through three segments: Healthcare, Financial Services and Information Management. Its Healthcare segment includes pharma solutions, critical care, consumer products and imaging. Its Financial Services segment includes wholesale lending, alternative asset management and investments in Shriram Group. Its Information Management segment is engaged in Decision Resources Group (DRG). DRG's product and services portfolio consists of data and analytics, research products and global consulting services. The Company offers its products under brands, including Saridon, Lacto Calamine, i-pill/i-know, Polycrol, Tetmosol, Untox, Stop AllerG and Throatsil.

Company Address

Piramal Enterprises Ltd

10th floor, Piramal Tower
Ganpatrao Kadam Marg
Lower Parel
MUMBAI     400083
P: +9122.30956666
F: +9122.24902363

Company Web Links